Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administered as DNA vaccines; and CLICK’N CUT, a tool to obtain tag-less proteins in a one-step process based on intein affinity, as well as Zebrafish assays. The company is based in Cádiz, Spain.
Metrics to compare | BSTY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSTYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.6x | −1.1x | −0.5x | |
PEG Ratio | - | 0.03 | 0.00 | |
Price/Book | 2.1x | 2.2x | 2.6x | |
Price / LTM Sales | 4.5x | 2.8x | 3.3x | |
Upside (Analyst Target) | - | 120.1% | 46.6% | |
Fair Value Upside | Unlock | 4.9% | 6.4% | Unlock |